Purification of Toxoplasma antigen for hemagglutination tests.

K. Fujita,K. Kamei,T. Fujita,K. Shioiri‐Nakano,Y. Tsunematsu

DOI: https://doi.org/10.4269/AJTMH.1969.18.892

1969-11-01

American Journal of Tropical Medicine and Hygiene

Abstract:

What problem does this paper attempt to address?

Life quality, depression, and anxiety levels in parents of children with primary immunodeficiency

Sibel Kaplan Sarıkavak,Talat Sarıkavak,Özge Türkyılmaz Uçar,Çiğdem Aydoğmuş,Mehmet Halil Celiksoy

DOI: https://doi.org/10.1111/pai.14068

2024-01-13

Pediatric Allergy and Immunology

Abstract:Background Primary immune deficiencies (PID) encompasses genetic disorders that result in recurrent infections and immune dysregulation, often increasing the risk of malignancies. The aim of this study is to determine the quality of life, depression, and anxiety in parents of children with PID. Methods Various validated assessment tools, including the Beck Depression Inventory (BDI), State and Trait Anxiety Inventory (STAI), the 36‐item Short Form Survey (SF‐36), and a demographic form, were employed to gather data from 85 parents of 64 PID patients and 85 parents of 75 healthy children. Results The findings reveal that parents of PID patients exhibited higher BDI, STAI‐S, STAI‐T, and fatigue subdomain of SF‐36 (p = .013, p = .013, p = .027, p = .000). Both parents had lower energy levels than the normal population, but mothers experienced higher levels of anxiety and depression. PID mothers' had higher scores than fathers of PID patients with healthy children in BDI, STAI‐S, and STAI‐T (p = .002, p = .010, p = .001). Mothers of PID patients reported lower scores in RLEP, E/F, EWB, P, and GH compared to fathers (p = .009, p = .005, p = .034, p = .001, p = .003). Additionally, the study found that STAI‐T influenced all subdimensions of HRQOL. These results highlight the substantial emotional and psychological burden placed on parents caring for children with PID. Conclusion The study underscores the importance of supporting caregivers to enhance the overall well‐being of both parents and children with PID. Such support can potentially alleviate depression and anxiety levels among parents, ultimately improving their quality of life and aiding in the management of children with PID.

pediatrics,immunology,allergy
Sustained release spherical agglomerates of polymethacrylates containing mefenamic acid: in vitro release, micromeritic properties and histological studies

M. Ozyazici,F. Sevgi,Ç. Pekçetin,B. Sarpas,Safak Sayin

DOI: https://doi.org/10.3109/10837450.2010.550621

2012-06-14

Abstract:Mefenamic acid (MA) spherical agglomerates (SAs) were prepared with various polymethacrylates having different permeability characteristics (Eudragit RS 100, Eudragit RL 100 and Eudragit L 100) and also with combination of Eudragit RS 100 and Eudragit L 100 in different ratios. SAs were prepared by spherical crystallization method using ethanol/dichloromethane solvent (crystallization) system. The influence of various formulation factors on the encapsulation efficiency, as in vitro drug release, and micromeritic properties was investigated. Target release profile of MA was also drawn. The yields of preparation and the encapsulation efficiencies were high for all formulations. The shape and surface characteristics of SAs were observed by a scanning electron microscope. The particle sizes are in the range of 0.219 ± 0.1 to 0.482 ± 0.25 mm (mean ± confidence interval t95%). In addition, histological studies showed that the administration of MA in SAs containing Eudragit RS/L provided a distinct tissue protection in the stomach and duodenum. Differential scanning calorimetry and X-ray diffraction of powder studies showed that MA particles crystallized in the presence of polymethacrylates did not undergo structural modifications.
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes

Mark Ballow

DOI: https://doi.org/10.2500/aap.2024.45.240056

2024-09-01

Allergy and Asthma Proceedings

Abstract:Quality of life (QOL) measures have become increasingly important in the management of patients with complex diseases. There are a number of instruments to measure QOL that include broad areas or domains of physical, psychological, social, spiritual, and environmental issues. The number of potential domains plus the large number of items within each domain have led to the development of a large variety of QOL instruments and of different approaches by using both health-related and non‐health-related factors. Health-related QOL (HRQOL) measures have been incorporated into clinical trials to assess changes in the patient’s perspective on his or her disease and the effects of treatment. An important aspect of these HR-QOL instruments is that these questionnaires are patient reported and usually self-administered. The life-long therapy of intravenous immunoglobulin (IVIG) or subcutaneous immunoglobulin (SCIG) can be a challenge to the patient, his or her family and the physician. A number of patient-reported surveys have been published that examined treatment satisfaction and the comparison between IVIG and SCIG replacement therapy in patients with primary immunodeficiency. This review explores the use of HR-QOL surveys in patient preferences for mode and route of immunoglobulin therapy and site of care. Shared decision-making will be explored to emphasize the importance of this approach in optimizing patient care and compliance.

allergy
Improving Quality of Life in Pediatric Advanced Cancer: Results from the PediQUEST Response RCT (CO101C)

Veronica Dussel,Liliana Orellana,Maria L. Requena,Madeline Avery,Elisha Waldman,Tammy I. Kang,Justin N. Baker,Stefan J. Friedrichsdorf,Jason L. Freedman,Chris Feudtner,Abby R. Rosenberg,Christina K. Ullrich,Joanne Wolfe

DOI: https://doi.org/10.1016/j.jpainsymman.2024.02.487

IF: 5.576

2024-04-19

Journal of Pain and Symptom Management

Abstract:Outcomes 1. Develop ideas about ways to integrate palliative care into the care of children, adolescents, and young adults with advanced cancer. 2. Develop ideas about ways to integrate electronic patient reported outcome measures into the care of children, adolescents, and young adults with advanced cancer. Key Message PediQUEST Response is an intervention for children with advanced cancer that combines e-PROMS and specialty palliative care integration. Parents of children receiving the intervention reported better child quality of life compared to controls. This is the first RCT to show the positive impact of palliative care in pediatric oncology. Importance Evidence about the impact of specialty pediatric palliative care (SPPC) is low.(1) Pediatric Quality of Life and Evaluation of Symptoms Technology Response to Pediatric Oncology Symptom Experience (PQ-Response) aims to integrate SPPC into the routine care of pediatric advanced cancer patients. Objectives To evaluate whether PQ-Response, compared to usual care, improves patient's health related quality of life (HRQoL) as reported by parents. Scientific Methods Utilized Multisite, randomized (1:1; allocation concealed), controlled, un-blinded trial comparing PQ-Response (intervention) to usual cancer care (control) conducted at five large pediatric cancer centers.(2) Participants: Children ≥2 years old (+1 parent) with advanced cancer, SPPC "naïve," and receiving longitudinal care at the site. Interventions: PQ-Response combined the use of the PQ-web/app to provide feedback of patient- and parent-reported child symptoms and HRQoL to families and clinicians with integration of SPPC. Usual Cancer Care: participants answered PQ-surveys (no feedback provided) and received usual care. Procedures: Patients ≥5 years old and parents answered weekly PQ-Surveys assessing symptom distress and HRQoL (Pediatric Quality of Life Inventory 4.0 (PedsQL)). After a 2-week run-in period, dyads who answered ≥2 PQ-surveys/participant were randomized and followed for 16-weeks. Primary outcome: mean parent-reported patient HRQoL score (0-100, 100 better) over 16-weeks. Child-reported outcomes and symptom distress are not reported here. Results We enrolled 196 patients, 154 were randomized; analysis included 152 who reported ≥1 HRQoL score during follow-up (74 Intervention/ 78 Control). Child's mean age was 11 years, 49% were female, 45% had brain tumors, 39% solid tumors, and 16% hematologic malignancies. PQ-Response was associated with improvements in PedsQL total (3.4; 95%CI: 0.5, 6.4; p=0.024) and physical scores (4.5; 95%CI: 0.3, 8.7; p=0.034). Conclusion(s) PQ-Response was associated with improvement in child HRQoL. Impact Integration of SPPC combined with routine feedback about symptoms and HRQoL leads to better child quality of life in pediatric advanced cancer. ClinicalTrials.gov (NCT03408314) – NINR/NIH Keywords Pediatrics Palliative care in oncology

medicine, general & internal,clinical neurology,health care sciences & services
Differential effect of a patient-education transition intervention in adolescents with IBD vs. diabetes

Silke Schmidt,Henriette Markwart,Franziska Bomba,Holger Muehlan,Annette Findeisen,Martina Kohl,Ingo Menrath,Ute Thyen

DOI: https://doi.org/10.1007/s00431-017-3080-z

Abstract:Patient education programs (PEPs) to improve disease management are part of standard and regular treatment in adolescents with diabetes. In Germany, youth with inflammatory bowel disease (IBD) receive individual counseling but not PEPs in group settings. Generic PEPs have been developed in order to improve transition from child-centered to adolescent health services. The aim of the study was to investigate the effects of a transition-oriented PEP on quality of life (QoL) and self-management in young patients with IBD (PEP naive), compared to patients with diabetes (familiar with PEPs). A 2-day transition workshop was oriented at improving psychosocial skills and addressed both generic as well as specific aspects of the condition. A controlled trial on the outcomes of a generic transition-oriented PEP was conducted in 14- to 20-year-old patients with IBD (n = 99) and diabetes (n = 153). Transition competence and QoL were assessed at baseline and 6-month follow-up. Results show that the intervention lead to a significant increase in QoL only in patients with IBD. The PEP significantly improved transition competence in both groups, however to a higher extent in subjects with IBD. Conclusion: Transition-oriented PEPs can have differential effects in different patient groups. However, this needs further longitudinal investigations. What is Known: • To date, evidence has accumulated concerning the effectiveness of patient education programs (PEPs) in pediatric health care for chronic conditions such as type 1 diabetes, asthma, atopic dermatitis, or obesity but is less documented in inflammatory bowel disease (IBD). In particular, PEPs in the transition period have not been investigated in youth with IBD. • The current study focuses on evaluating a PEP for transition preparation and management designed to be generically used across different chronic conditions since many aspects of managing chronic conditions share commonalities across conditions. The 2-day workshop included condition-specific modules adapted to the specific medical needs but was otherwise similar in quality and organization among different conditions. What is New: • The transition-oriented PEP was effective in enhancing self-management and transition management skills in both patients with IBD and diabetes; however, effects were higher in youth with IBD. A significant impact of the intervention on patients' QoL compared to the control group was only identified in youth with IBD. • We recommend that patients with IBD have access to PEP as a standard treatment as well as to a transition program during the course of illness.
The German National Registry of Primary Immunodeficiencies (2012-2017)

Sabine M El-Helou,Anika-Kerstin Biegner,Sebastian Bode,Stephan R Ehl,Maximilian Heeg,Maria E Maccari,Henrike Ritterbusch,Carsten Speckmann,Stephan Rusch,Raphael Scheible,Klaus Warnatz,Faranaz Atschekzei,Renata Beider,Diana Ernst,Stev Gerschmann,Alexandra Jablonka,Gudrun Mielke,Reinhold E Schmidt,Gesine Schürmann,Georgios Sogkas,Ulrich H Baumann,Christian Klemann,Dorothee Viemann,Horst von Bernuth,Renate Krüger,Leif G Hanitsch,Carmen M Scheibenbogen,Kirsten Wittke,Michael H Albert,Anna Eichinger,Fabian Hauck,Christoph Klein,Anita Rack-Hoch,Franz M Sollinger,Anne Avila,Michael Borte,Stephan Borte,Maria Fasshauer,Anja Hauenherm,Nils Kellner,Anna H Müller,Anett Ülzen,Peter Bader,Shahrzad Bakhtiar,Jae-Yun Lee,Ursula Heß,Ralf Schubert,Sandra Wölke,Stefan Zielen,Sujal Ghosh,Hans-Juergen Laws,Jennifer Neubert,Prasad T Oommen,Manfred Hönig,Ansgar Schulz,Sandra Steinmann,Klaus Schwarz,Gregor Dückers,Beate Lamers,Vanessa Langemeyer,Tim Niehues,Sonu Shai,Dagmar Graf,Carmen Müglich,Marc T Schmalzing,Eva C Schwaneck,Hans-Peter Tony,Johannes Dirks,Gabriele Haase,Johannes G Liese,Henner Morbach,Dirk Foell,Antje Hellige,Helmut Wittkowski,Katja Masjosthusmann,Michael Mohr,Linda Geberzahn,Christian M Hedrich,Christiane Müller,Angela Rösen-Wolff,Joachim Roesler,Antje Zimmermann,Uta Behrends,Nikolaus Rieber,Uwe Schauer,Rupert Handgretinger,Ursula Holzer,Jörg Henes,Lothar Kanz,Christoph Boesecke,Jürgen K Rockstroh,Carolynne Schwarze-Zander,Jan-Christian Wasmuth,Dagmar Dilloo,Brigitte Hülsmann,Stefan Schönberger,Stefan Schreiber,Rainald Zeuner,Tobias Ankermann,Philipp von Bismarck,Hans-Iko Huppertz,Petra Kaiser-Labusch,Johann Greil,Donate Jakoby,Andreas E Kulozik,Markus Metzler,Nora Naumann-Bartsch,Bettina Sobik,Norbert Graf,Sabine Heine,Robin Kobbe,Kai Lehmberg,Ingo Müller,Friedrich Herrmann,Gerd Horneff,Ariane Klein,Joachim Peitz,Nadine Schmidt,Stefan Bielack,Ute Groß-Wieltsch,Carl F Classen,Jessica Klasen,Peter Deutz,Dirk Kamitz,Lisa Lassay,Klaus Tenbrock,Norbert Wagner,Benedikt Bernbeck,Bastian Brummel,Eusebia Lara-Villacanas,Esther Münstermann,Dominik T Schneider,Nadine Tietsch,Marco Westkemper,Michael Weiß,Christof Kramm,Ingrid Kühnle,Silke Kullmann,Hermann Girschick,Christof Specker,Elisabeth Vinnemeier-Laubenthal,Henriette Haenicke,Claudia Schulz,Lothar Schweigerer,Thomas G Müller,Martina Stiefel,Bernd H Belohradsky,Veronika Soetedjo,Gerhard Kindle,Bodo Grimbacher

DOI: https://doi.org/10.3389/fimmu.2019.01272

2019-07-19

Abstract:Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs. Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel. Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1-25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0-88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE- syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%-subcutaneous; 29%-intravenous; 1%-unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy. Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.
Insights into Patient Experiences with Facilitated Subcutaneous Immunoglobulin Therapy in Primary Immune Deficiency: A Prospective Observational Cohort

Ezgi Yalcin Gungoren,Melek Yorgun Altunbas,Ummugulsum Dikici,Zeynep Meric,Isil Eser Simsek,Ayca Kiykim,Salim Can,Esra Karabiber,Nalan Yakici,Fazil Orhan,Haluk Cokugras,Metin Aydogan,Oner Ozdemir,Sevgi Bilgic Eltan,Safa Baris,Ahmet Ozen,Elif Karakoc-Aydiner

DOI: https://doi.org/10.1007/s10875-024-01771-0

2024-08-05

Abstract:Background: Immunoglobulin G replacement therapy (IgRT), intravenous (IV) and subcutaneous (SC) routes, is pivotal in treatment of primary immunodeficiencies (PID). In recent years, facilitated subcutaneous immunoglobulin (fSCIG), a combination of rHuPH20 and 10% IgG has emerged as a delivery method to combine advantages of both IV and SC. Method: In an observational prospective cohort, we investigated patient experience with fSCIG in PID patients from 5 PID centers for up to 12 months. We assessed the efficacy and safety of this treatment with patient/caregiver- and physician-reported indicators. Additionally, we analyzed patient treatment satisfaction (TSQM-9) and quality of life (QoL). Results: We enrolled 29 patients (22 pediatric and 7 adults; 14 females and 15 males; (median: 15, min-max: 2-40.9 years) who initiated fSCIG as IgRT-naive (n = 1), switched from conventional rapid-push 10% SCIG (n = 6) or IVIG (n = 22). Among the participants, 19 (65%) exhibited antibody deficiencies, 8 (27%) combined immunodeficiencies, and 2 (7%) immune dysregulations. Remarkably, targeted trough immunoglobulin G levels were achieved under all previous IgRTs as well as fSCIG. No severe systemic adverse drug reactions were documented, despite prevalent local (%86.45) and mild systemic (%26.45) adverse reactions were noted with fSCIG. Due to mild systemic symptoms, 2 patients switched from fSCIG to 10% SCIG. The patient satisfaction survey revealed a notable increase at 2-4th (p = 0.102); 5-8th (p = 0.006) and 9-12th (p < 0.001) months compared to the baseline. No significant trends were observed in QoL surveys. Conclusion: fSCIG demonstrates admissable tolerability and efficacy in managing PIDs in addition to notable increase of patients' drug satisfaction with IgRT. The identified benefits support the continuation of this therapy despite the local reactions.
A psychological perspective for double‐blind trials

S. Zifferblatt,C. Wilbur

DOI: https://doi.org/10.1002/cpt19782311

1978-01-01

Clinical pharmacology and therapy

Abstract:Blind breaking is likely to occur in a long‐term clinical trial involving subjects at risk. Double‐blind conditions require subjects to live with ambiguity regarding their health status. lt is unrealistic to expect them to tolerate this ambiguity over an extended period of time. A logical step for a subject is to break the blind and surreptitiously seek the best medical care available. Moreover, the staff assigned to monitor protocol adherence may further contribute to blind breaking because of ambiguity regarding their proper clinical role. Several steps are recommended to manage blind breaking within a trial, including improving the quality of medical care, more rigorous screening procedures, and maintaining a clinical environment that promotes accurate disclosure of blind breaking.
Evaluation of awareness about primary immunodeficiencies among physicians before and after implementation of the educational program: A longitudinal study

Tetyana Hariyan,Maria Kinash,Roman Kovalenko,Oksana Boyarchuk

DOI: https://doi.org/10.1371/journal.pone.0233342

IF: 3.7

2020-05-29

PLoS ONE

Abstract:Increasing physicians' awareness is one of the main ways to improve early diagnosis of rare diseases. A survey among physicians of different specialties to evaluate the knowledge about primary immunodeficiencies (PID) was conducted in 2016 and in 2019 –before and after the implementation of an educational program. We compare responses from 82 doctors who participated in the 2016 survey, and 67 doctors who have taken part in the survey in 2019: pediatricians, general practitioners / family physicians and physicians of pediatric sub specialties. The percentage of correct answers to all survey questions after the implementation of the educational program has significantly increased (79.0% in 2019 versus 58.3% in 2016, P<0.0001). This increase in the percentage of correct answers was noted among the surveyed doctors of all specialties. Particular progress was found among pediatricians, who have achieved more than 80% of correct answers. In 2019 the doctors demonstrated better knowledge on the warning signs of PID and specific features of Nijmegen breakage syndrome, DiGeorge syndrome and ataxia-telangiectasia syndrome. Thus, the implementation of an educational program improved physicians' awareness of PIDs, and will contribute to early detection of PIDs and their medical care.

multidisciplinary sciences
The puppet interview to measure illness perceptions in paediatric oncology: development and psychometric properties in acute treatment and follow-up care

Kristina Herzog,Florian Schepper,Jessy Herrmann,Julia Martini

DOI: https://doi.org/10.1186/s12887-024-04586-5

2024-02-13

BMC Pediatrics

Abstract:Abstract Background Illness perceptions comprise assumptions about symptoms, timeline, consequences, controllability, and emotional responses to an illness. Recent evidence shows that illness perceptions are associated with coping and well-being. So far, assessment in paediatric care was based on parental report only, since no instrument for the direct assessment of young children was available. We aim to describe the development (incl. indication and contraindication) of an innovative puppet interview to assess illness perceptions in children with cancer from the age of four years. Moreover, we investigate longitudinal trajectories and examine psychometric properties. Methods The puppet interview was developed based on the Illness-Perception-Questionnaire-Revised and the Berkeley-Puppet-Interview. Longitudinal trajectories and psychometric properties were examined in a sample of patient-parent dyads ( N = 75) in a prospective longitudinal study in acute treatment with a 1-year follow-up (study 1: n T1 = 41, n T2 = 27) and in a cross-sectional study in follow-up care (study 2, n = 34). Results The puppet interview is comprehensible and well-received by children in acute treatment and follow-up care. There were significant differences in perceptions of a chronic timeline ( U = 301.00, p = .008), consequences ( U = 251.00, p = .008), and emotional representations ( U = 244.50, p = .020) between children in acute treatment and children in follow-up care. Over the course of one year, children in acute treatment perceived more symptoms as part of their illness ( M T1 = 3.6, SD T1 = 2.9, M T2 = 4.5, SD T2 = 3.1, n = 27, Z = -2.603, p = .009). We found expected intercorrelations between illness perception dimensions, e.g. between perception of consequences and emotional representations ( r τ = .27, p = .033), and between perception of a chronic timeline and consequences ( r τ = .38, p = .001). Moreover, we found confirming results regarding construct validity, as child’s perceptions of symptoms correlated with their self-rated HRQoL ( r τ = -.32, p adj. = .014). Also parent-rated subscale on illness-specific aspects of child’s HRQoL correlated with child’s perception of symptoms ( r τ = -.26, p adj. = .016), cyclicity ( r τ = -.28, p adj. = .016), and consequences ( r τ = -.34, p adj. = .014). Acceptable internal consistency was shown for the dimensions timeline-acute/chronic and personal control. Conclusions Parental report can now be complemented by a self-report of illness perceptions in children aged four years and older. This will allow for the further adaptation of medical and psychosocial care during and after acute cancer treatment. Trial registration The study has been pre-registered at the German Clinical Trials Register (registered 30/06/2020; DRK-S00022034) and at the Open Science Foundation ( https://osf.io/7xr6z ).

pediatrics
[Fibromuscular dysplasia of the brachial artery--2 case reports and review of the literature].

H. Haueisen,P. Stierli,T. Roeren

Abstract:Yet being an uncommon disease in general, the manifestation of the fibromuscular dysplasia (FMD) in the upper extremities is exceedingly rare. Two patients with FMD of the brachial artery are presented and the literature concerned is reviewed. In this location the formation of microthrombi with subsequent embolization into the periphery instead of progressive vessel stenosis seems to be the leading pathophysiological principle. Therapeutic options are discussed.
The impact of posterior urethral valves on pediatric quality of life and family function: Prospective analysis of serial patients managed in a dedicated multidisciplinary clinic

Mandy Rickard,Armando J. Lorenzo,Noreen Goraya,Jin Jyu Kim,Adree Khondker,Priyank Yadav,Juliane Richter,Michael Chua,Joana Dos Santos

DOI: https://doi.org/10.1016/j.jpurol.2024.05.008

IF: 1.921

2024-05-18

Journal of Pediatric Urology

Abstract:Summary Introduction Posterior urethral valves (PUV) is a chronic condition that can adversely impact child and family health related quality of life (HRQOL). Surprisingly, to date, the impact of this condition on the QOL of children with PUV has not been studied. Thus, our aim is to evaluate this important aspect of care using validated questionnaires in our institutional PUV clinic. Methods From December 2022 to January 2024, the PedsQL Inventory and associated family impact module was distributed in our PUV clinic. Higher scores reflect better HRQoL and less impact on family. Children >8 years old completed the tool themselves, otherwise parents completed the tools on behalf of the child. We compared PUV scores against reported psychometric data from healthy children and other chronic illnesses. Results A total of 112 families completed the questionnaires. The total HRQoL score was 80 +/- 13. Overall, we noted that the domains reflecting psychosocial impact were significantly lower than those of physical well-being (76 +/- 16 vs. 89 +/- 15 for psychosocial and physical impact, respectively; p<0.01). There was a significant difference in the psychosocial emotional impact for children managed with clean intermittent catheterization (CIC) compared to those who were not (69 +/- 21 vs. 81 +/- 16; p=0.005) ( Table 2 ). In addition, we noted that children with PUV scored similar to healthy controls, but higher than children with other chronic illnesses. With respect to the impact on family, overall, parent, and family impacts were 76 +/- 19, 78 +/- 21, and 81 +/- 21, respectively. Discussion Chronic illness has been associated with a negative impact on HRQoL in both adults and children. We noted similar findings the present study, particularly for young children and those who are maintained on CIC. To our knowledge, this is the first study to evaluate the impact of PUV on a child's HRQoL as well as the impact on the family, and to document a negative psychosocial impact of CIC in this population. However, there are some important limitations to be addressed including relying on families to complete questionnaires accurately during busy clinic visits and the lack of controls from the same environment. Conclusion When compared to healthy controls, PUV patients score similarly in HRQoL assessment. In addition, children <3years of age report a negative impact on physical well being, and CIC negatively impacts the emotional well-being. These data can be used to advocate for better mental health supports and social work for these children.

pediatrics,urology & nephrology
The Effectiveness of a Parent Empowerment Intervention for Caregivers of Children with Cystic Fibrosis: A Randomized Controlled Trial

Hatice Donmez,Fatma Tas Arslan

DOI: https://doi.org/10.1080/24694193.2024.2411986

Abstract:This paper focused on the effectiveness of a parent empowerment intervention based on nursing education (PEINE). This study examined whether the intervention improved the quality of life of children with cystic fibrosis (CF) and improved their caregivers learn about the disease and develop problem-solving and coping skills. This randomized-controlled trial used a pretest-posttest parallel-group research design. The sample consisted of 48 parents (caregivers) of children with CF. Participants were randomly assigned to an intervention (n = 24) and a control group (n = 24). The intervention group received PEINE and standard care and treatment for ten weeks. The control group received standard care and treatment. Data were collected using a Disease Information Survey (DIS), the Ways of Coping Inventory (WCI), the Problem-Solving Inventory (PSI), and the Cystic Fibrosis Questionnaire (CFQ-R). After the intervention, the intervention group DIS scores (d: 1,627 [CI: 0.934,2.305], had more correct answers than the control group. Nursing interventions were effective (p < .001). There was no significant difference in the mean pretest-posttest PSI scores (d: 0.378 [CI: -0.221-0.972], posttest WCI scores (d: 0.239 [CI:-0.356-0.831]) between the intervention and control groups (p>.05). There was a significant difference in the mean posttest CFQ-R scores between the intervention and control groups (d: 1.363 [CI: l.698, 2.015]);(p < .001). PEINE increased the intervention group participants develop disease-management skills. However, the increase in their PSI and WCI scores was statistically insignificant. PEINE also increased the quality of life of children with CF. Parents of children followed in pediatric pulmonary diseases participated in the study. Parents were informed during outpatient clinic visits. After the first meeting, the children and parents who voluntarily agreed to participate in the research were contacted by phone. The outpatient nurse assisted in communicating with children and parents.
Improving the assessment and treatment of pelvic inflammatory disease among adolescents in an urban children's hospital emergency department

Colleen A McCallum,Kathleen S Oman,Mary Beth Flynn Makic

DOI: https://doi.org/10.1016/j.jen.2013.09.015

Abstract:Introduction: Proper pelvic inflammatory disease (PID) assessment and treatment is essential in preventing ectopic pregnancies, repeated PID infections, infertility, chronic pelvic pain, and fetal death. This project measured the effectiveness of interventions directed toward the providers in the emergency department to facilitate a change in the assessment and treatment of PID. Two aims identified for the project included increasing the number of providers who recorded a correct diagnosis of PID in the chart and included a sexual history for female adolescents who presented to the emergency department with abdominal pain. An additional aim was to increase the percentage of adolescents who received the correct treatment for PID. Methods: A quality improvement study using pre-post design and Plan-Do-Study-Act cycles over an 18-month period was conducted in the emergency department of an urban children's hospital. Assessment of adolescent female patients' history of recent sexual activity and correct diagnosis and treatment of PID were evaluated. Process improvement interventions consisted of PowerPoint presentations, educational materials, and Centers for Disease Control and Prevention (CDC) treatment guidelines posted in provider areas (Table 1), along with ongoing positive and corrective feedback to providers. Results: A total of 602 patient records were reviewed (119 in the PID diagnosis and treatment arm and 483 in the obtaining sexual history arm). After process improvement interventions, correct PID diagnosis increased from 72% to 95% (z = 3.064, P = .00109, odds ratio [OR] = 7.08). Correct PID treatment increased from 39.3% to 79.3% (z = 4.190, P = .0000139, OR = 5.90). The percentage of providers who obtained a sexual history increased from 65% to 74.2% (z = 1.892, P = .02929, OR = 1.55). Discussion: The study demonstrated a significant improvement in all 3 aims related to improved care of adolescents with PID. PowerPoint presentations and the physical presence of the CDC treatment guidelines in the provider treatment areas were instrumental for success. Nurses play a pivotal role in the implementation and success of quality improvement projects for improving patient outcomes.
The expected discounted penalty function under a risk model with stochastic income

C. Labbé,Kristina P. Sendova

DOI: https://doi.org/10.1016/j.amc.2009.07.049

IF: 4.397

2009-11-01

Applied Mathematics and Computation

Abstract:
P203 Surveying outcomes of service user experience on the effects of emotional well-being and schooling in paediatric IBD (PIBD) patients in a tertiary PIBD centre

C Lashley,R Buckingham,B Huggett,T Sawney,S Chadokufa,F Kiparissi,A Elzein

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0333

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background We conducted a prospective survey with our PIBD patients and parents seeking outcomes in accordance with our ICN- Improve Care Now participation goals to ‘Improve and optimize the care of children and teens with IBD in underserved and underrepresented populations by addressing healthcare disparities’. Methods We sent out a survey to our PIBD patients focusing on their overall satisfaction with the service we deliver in relation to their emotional wellbeing and schooling. We prospectively sent this to our patient cohort of 280 PIBD patients, collecting both quantitative and qualitative data. Results 76/280 patients and parents (27%) responded, of whom 60/76 (79%) completed the entire survey. Of those responders 45 (75%) were mothers speaking on the behalf of their children aged 5-12 years (n=20 patients). 4 (7%) patients completed the survey themselves, of whom 3 (75%) were aged between 12-18 years. 39 (65%) parents and patients were overall satisfied that the IBD team spoke about getting the right help and support for the child at school. Although 39 (65%) of the patients strongly agreed that we provided information and materials on IBD and support, 21 (35%) of the patients felt that we did not provide the necessary information and education to schools to support them whilst at school.30 (50%) of the overall responders to the survey did not feel that the team had discussed with them the effect IBD has on their feelings and emotions. Conclusion Our survey has highlighted the need to provide more education at diagnosis and throughout patient care. This can be achieved by providing physical education packs for schools to be given to every child at diagnosis along with our already established welcome pack. We currently ask patients and families if they would like us to contact their school with information about IBD. This is something we can potentially change, by giving all patients a letter for school at diagnosis for them to give to schools. Caring for the patient’s emotional wellbeing is essential as part of delivering a holistic approach in the care we provide. Although we do offer referral to psychology at diagnosis, this should be followed up regularly and should be included as a standard when patients seen in clinics.

gastroenterology & hepatology
Prospective study of the effect of auricular percutaneous electrical nerve field stimulation on quality of life in children with pain related disorders of gut-brain interaction

Ashish Chogle,Kaajal Visnagra,Jamie Janchoi,Tammy Tran,Rachel Davis,Nicole Callas,Elisa Ornelas

DOI: https://doi.org/10.3389/fpain.2023.1223932

2023-09-08

Frontiers in Pain Research

Abstract:Background Disorders of the Gut-Brain Interaction (DGBIs) account for 50% of pediatric gastrointestinal (GI) consultations. Children with DGBIs have worse quality of life (QoL) than those with organic GI disorders such as inflammatory bowel disease and gastroesophageal reflux disease. Pediatric DGBIs patients, especially those with chronic abdominal pain (AP), have impaired QoL and increased psychological distress in the form of anxiety and depression. Percutaneous Electrical Nerve Field Stimulation (PENFS) therapy has been shown to be effective in improving symptoms and functioning in children with DGBIs. The treatment's impact on these patients' QoL is unknown. Methods This prospective study evaluated changes in QoL, gastrointestinal symptoms, functional disability, somatization, global health, anxiety, and depression in patients aged 11–18 years who received PENFS therapy (IB-stim, NeurAxis, Versailles, IN) for treatment of pain related DGBIs, once a week for four consecutive weeks. Results This study included 31 patients with an average age of 15.7 years (SD = 2); 80.6% were female. After PENFS therapy, patients reported significant reductions in abdominal pain, nausea severity, functional disability, somatization, and anxiety from baseline to week 4 ( p < 0.05). Parents reported significant improvement in their child's QoL regarding physical function, psychosocial function, and generic core scale scores ( p < 0.05). Parents also noted reduced abdominal pain, functional disability, and somatization. Average scores on the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale significantly improved based on both patient and parent reports ( p < 0.05). Our patients' QoL was significantly lower than healthy controls at baseline and after treatment ( p < 0.05). Conclusion Our research demonstrates that PENFS significantly enhances the QoL of children suffering from pain-related DGBIs, in addition to improvement in GI symptoms, daily functioning, somatization, global health, and psychological comorbidities. These findings demonstrate the effectiveness of PENFS and its potential to alleviate the suffering of countless children.
Psychosocial Evaluation of Adults with Primary Immunodeficiency

Reyhan Gumusburun,Sevgi Altay,Hasancan Cengiz,Gulendam Hakverdioglu Yont,Ozlem Kuman Tuncel,Omur Ardeniz

DOI: https://doi.org/10.1007/s10875-024-01671-3

IF: 8.542

2024-02-29

Journal of Clinical Immunology

Abstract:Primary immunodeficiency disorder (PID) is a heterogeneous group of diseases characterized by immune dysregulation and increased susceptibility to infections, with various cognitive, emotional, behavioral, and social effects on patients. This study aimed to evaluate loneliness, social adaptation, anxiety, and depression and to identify associated factors in adults with immunodeficiency.

immunology
Non-Pharmacologic Intensive Interdisciplinary Pain Treatment in Pediatrics: Impact on Symptoms, Daily Functioning, and the Family Unit

Jessica Campanile,Becky Wu,Maitry Sonagra,Mackenzie McGill,Daneka Stryker,Jamie Bradford,Jennifer Sherker,Tami Konieczny,David D. Sherry,Sabrina Gmuca

DOI: https://doi.org/10.3390/children11020197

2024-02-04

Children

Abstract:Objectives: To assess non-pharmacologic treatment outcomes pertaining to health-related quality of life (HRQoL) in youth with chronic idiopathic pain and their families. Methods: We conducted a retrospective cohort study of 115 youth with chronic idiopathic pain enrolled in a non-pharmacologic, hospital-based intensive interdisciplinary pain treatment (IIPT) program. HRQoL measures for the patient (Pediatric Quality of Life Inventory [PedsQL] short form) and family unit (PedsQL Family Impact) were collected on admission and discharge as part of routine clinical care. Changes in PedsQL scores were calculated using the Wilcoxon signed-rank test. Multivariable linear regression was used to explore factors associated with patient-level HRQoL. Results: Both individuals and the family unit reported that their HRQoL improved in all domains by program completion. Improvements in pain and allodynia were present for program participants at the time of completion as well as at the 3-month follow-up, suggesting durability of these effects. Conclusions: A non-pharmacologic IIPT program is a compelling treatment for pediatric and adolescent chronic idiopathic pain, for both patients and the family unit. Patients participating in this program had positive treatment outcomes with significantly improved subjective and objective measures of physical, emotional, social, and cognitive function.

pediatrics
Improving the patient-centred care of children with life-altering skin conditions using feedback from electronic patient-reported outcome measures: protocol for a hybrid effectiveness-implementation study (PEDS-ePROM)

Zephanie Tyack,Megan Simons,Steven M McPhail,Gillian Harvey,Tania Zappala,Robert S Ware,Roy M Kimble

DOI: https://doi.org/10.1136/bmjopen-2020-041861

IF: 3.006

2021-04-01

BMJ Open

Abstract:Introduction Using patient-reported outcome measures (PROMs) with children have been described as ‘giving a voice to the child’. Few studies have examined the routine use of these measures as potentially therapeutic interventions. This study aims to investigate: (1) the effectiveness of feedback using graphical displays of information from electronic PROMs (ePROMs) that target health-related quality of life, to improve health outcomes, referrals and treatment satisfaction and (2) the implementation of ePROMs and graphical displays by assessing acceptability, sustainability, cost, fidelity and context of the intervention and study processes. Methods and analysis A hybrid II effectiveness-implementation study will be conducted from February 2020 with children with life-altering skin conditions attending two outpatient clinics at a specialist paediatric children’s hospital. A pragmatic randomised controlled trial and mixed methods process evaluation will be completed. Randomisation will occur at the child participant level. Children or parent proxies completing baseline ePROMs will be randomised to: (1) completion of ePROMs plus graphical displays of ePROM results to treating clinicians in consultations, versus (2) completion of ePROMs without graphical display of ePROM results. The primary outcome of the effectiveness trial will be overall health-related quality of life of children. Secondary outcomes will include other health-related quality of life outcomes (eg, child psychosocial and physical health, parent psychosocial health), referrals and treatment satisfaction. Trial data will be primarily analysed using linear mixed-effects models; and implementation data using inductive thematic analysis of interviews, meeting minutes, observational field notes and study communication mapped to the Consolidated Framework for Implementation Research. Ethics and dissemination Ethical approval was obtained from Children’s Health Queensland Human Research Ethics Committee (HREC/2019/QCHQ/56290), The University of Queensland (2019002233) and Queensland University of Technology (1900000847). Dissemination will occur through stakeholder groups, scientific meetings and peer-reviewed publications. Trial registration number Australian New Zealand Clinical Trials Registry (ACTRN12620000174987).

medicine, general & internal

Purification of Toxoplasma antigen for hemagglutination tests.

Life quality, depression, and anxiety levels in parents of children with primary immunodeficiency

Sustained release spherical agglomerates of polymethacrylates containing mefenamic acid: in vitro release, micromeritic properties and histological studies

Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes

Improving Quality of Life in Pediatric Advanced Cancer: Results from the PediQUEST Response RCT (CO101C)

Differential effect of a patient-education transition intervention in adolescents with IBD vs. diabetes

The German National Registry of Primary Immunodeficiencies (2012-2017)

Insights into Patient Experiences with Facilitated Subcutaneous Immunoglobulin Therapy in Primary Immune Deficiency: A Prospective Observational Cohort

A psychological perspective for double‐blind trials

Evaluation of awareness about primary immunodeficiencies among physicians before and after implementation of the educational program: A longitudinal study

The puppet interview to measure illness perceptions in paediatric oncology: development and psychometric properties in acute treatment and follow-up care

[Fibromuscular dysplasia of the brachial artery--2 case reports and review of the literature].

The impact of posterior urethral valves on pediatric quality of life and family function: Prospective analysis of serial patients managed in a dedicated multidisciplinary clinic

The Effectiveness of a Parent Empowerment Intervention for Caregivers of Children with Cystic Fibrosis: A Randomized Controlled Trial

Improving the assessment and treatment of pelvic inflammatory disease among adolescents in an urban children's hospital emergency department

The expected discounted penalty function under a risk model with stochastic income

P203 Surveying outcomes of service user experience on the effects of emotional well-being and schooling in paediatric IBD (PIBD) patients in a tertiary PIBD centre

Prospective study of the effect of auricular percutaneous electrical nerve field stimulation on quality of life in children with pain related disorders of gut-brain interaction

Psychosocial Evaluation of Adults with Primary Immunodeficiency

Non-Pharmacologic Intensive Interdisciplinary Pain Treatment in Pediatrics: Impact on Symptoms, Daily Functioning, and the Family Unit

Improving the patient-centred care of children with life-altering skin conditions using feedback from electronic patient-reported outcome measures: protocol for a hybrid effectiveness-implementation study (PEDS-ePROM)